TH23219A - Various formulas for the treatment of complications of diabetes. - Google Patents

Abstract

The use of unsaturated fat acid at position -6a-6, especially Gamma linolenic acid (GLA), dihomogamma linolenic acid (DGLA) or arachidonic acid (ZZ), in combination with materials capable of Pharmacologically acceptable to lower levels within cells. Of sorbitol in the body, in particular asdosridicase inhibitors, in the therapy of (including preventive therapy) and in the preparation of medicinal substances for the treatment of (including Preventive therapy), long-term complications of diabetes mellitus, various pharmaceutical formulations of such materials; ascorbate ester of hypoallergenic acid Saturation to position -6A-6 (other than GLA or DGLA) by within the drug patent

Claims (3)

1. Pharmacy acceptable formulation of unsaturated fat acid at location -6g-6, especially Gamma linolenic acid (GLA), dihomogammalinolenic acid (DGLA) or arachidonic acid (AA), in combination with reducing materials The intracellular levels of sorbitol in the body, especially the inhibitors of lactose retort 2. Formulation according to claim 1 in which the substance is also ascorbate in such a way or in conjunction with it. 3. The formulation according to claim 2, of which Ascorbate is a specific type of ascorbic-EFA.